It has been observed before that participation in medical trials has been in favor of specific demographic groups. But research pointing out which trial attributes impact participation positively or negatively is sparse.

This study invites various participants to collect more data on their immunotherapy clinical experiences. The goal is to know which factors always limit how patients participate or complete the medical study they are first interested in.

The data obtained in the trial will be assessed through a variety of demographic lenses to discover patterns that might improve the experience of immunotherapy patients in the future.

Inclusion Criteria:

• Patient has self-identified as planning to participate in an interventional clinical trial using immunotherapy
• Patient has been diagnosed with a type of cancer
• Patient is a minimum of 18 years or older

Exclusion Criteria:

• Patient has an ECOG score of 4 or higher
• Patient is not able to provide consistent digital reporting as per study requirements
• Patient does not complete Informed Consent Form

Patients with cancer who are actively considering enrolling in an immunotherapy interventional clinical trials, but have not yet completed enrollment and randomization in said clinical trial.